This will likely be the last post in this series, at least for now, but last doesn’t mean least. The potential use of titre testing to inform vaccination decisions is an important issue that drives a lot of questions. A titre (or titer for our American friends) is a measure of the level of antibodies to a specific pathogen in the bloodstream. There are a number of different methods for doing titre testing that are quite well established.
TL;DR – In general, if someone asks me about using titres in lieu of vaccination, I tell them not to waste their money on titres. I’d rather have a discussion about what vaccines are truly needed for the animal in question, and the potential risks from vaccinating versus not vaccinating, and decide on a plan based on that. A pet’s vaccination history can usually tell me all I need about their likely level of protection, and titres don’t usually change that assessment.
It’s not a matter of titre testing results being incorrect. The issue is not knowing how to interpret them. Titres only look at antibodies in the bloodstream, but antibodies are just part of the immune response. The image below illustrates the other parts that are not measured by titres:

Cell-mediated immunity is critical for certain infections, particularly some viral infections, but we don’t have an effective means of measuring it, like we do with antibody titre testing.
Another important consideration is boostability of the immune response. This is dependent on the memory cells that are generated after vaccination or infection, which stand ready to produce more antibodies the next time the body encounters the same pathogen (or vaccine), even after the initial pool of antibodies produced dissipates over time. That anamnestic response can produce a large amount of antibody protection very quickly, but’s not something we can measure until it happens. An animal could have no detectable antibodies in circulation, but still be well protected because it’s able to produce a lot of antibodies quickly after re-exposure.
When blood is submitted for a titre, sometimes all the lab provides is the titre value. In some cases, labs also provide cutoff values for “positive” or “negative.” However, those cut-offs are probably best interpreted as “we’re confident there are antibodies” or “we’re confident there are a lot of antibodies.” We do not have established cutoffs for “protective” or “not protective.” Rabies titres are mainly used as proof of vaccination (particularly for international travel). Detectable antibody titres for some diseases (particularly canine distemper, parvovirus and adenovirus) are strongly associated with protection, but we still don’t have a specific titre that reliably tells us whether the animal is or is not likely to be protected. Low titres are harder to assess, since the animal may still have good protection from other components of the immune response, so I have more confidence in the vaccination history than the titres.
Despite all that, there are some niche situations where I would consider titres useful. For example:
- A 12-week-old puppy is vaccinated against rabies, distemper / adenovirus / parvovirus / parainfluenza (DAPP) and leptospirosis, and has a severe anaphylactic reaction. The owner is understandably concerned about giving the dog any more vaccines, and asks whether we can use titres instead to determine what vaccines are essential.
The answer in this case depends on the specific pathogen / vaccine:
Rabies: Rabies vaccines in Canada and the US are labeled for use in pets starting at 12 weeks of age, and the first dose is good for a year. If the puppy had a reasonable titre a month later, it means it responded as expected, and the next time the puppy is vaccinated it would likely have an even stronger response. But the titre would not exempt the dog from revaccination when it comes due 12 months later, because it doesn’t guarantee the dog is protected. We’ll still have to consider a rabies booster at that point, but at least but we’d have more information the dog will be older and hopefully stronger.
Distemper / adenovirus / parvovirus / parainfluenza: At 12 weeks of age, we are still concerned that there might be limited response to the vaccine because of interference from antibodies that the puppy has from its mother (maternal antibody interference).
- If the distemper and parvovirus titres are already moderate to high when the puppy reached 16 weeks of age, I’d be quite confident that those are not residual maternal antibodies (which wane over time) and that the puppy actually responded just fine to the vaccine at 12 weeks. If the puppy responded well, I expect it to have good protection for at least a year. We’d still have to consider whether the dog should have another booster when the year is up, as that would provide more confidence in long term protection, but as for the rabies vaccine, we could defer that decision at least until then.
- If the distemper and parvo titres are negative or very low at 16 weeks of age, I’d be concerned that the puppy didn’t responded adequately to the 12 week vaccines and might still be highly susceptible to these viruses. Then we have to have a discussion about whether to take the risk with another dose of the vaccine, or accept the risk that the puppy could get sick, and the impacts on the dog’s lifestyle (i.e. restricted from access to other dogs and areas where other dogs have been, to avoid exposure to these viruses).
Leptospirosis: We don’t have an option to test lepto titres to determine response to vaccination. We use microscopic agglutination testing (MAT) to look for antibodies as a diagnostic test in sick dogs, but we can’t use those to predict protection.
When someone asks about titre testing, the first thing I want to know is why. Are they concerned about adverse reactions? Are they worried about overvaccination? Are they trying to avoid vaccines altogether? Rather than jumping to titre testing, I’d rather review the animal’s vaccination history, consider its risk of exposure, and discuss the risks and benefits of vaccination versus not vaccinating. That discussion might lead to different decisions for different vaccines. While titres can sometimes help with those decisions in specific situations, they rarely avoid the need to make them.








